EVALDAS RADZEVICIUS: Open Payments
NPI 1750376869 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 79 payments from 18 companies in 2025. Trend: 2023 $2,328 · 2024 $2,334 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $436 |
| ABBVIE INC. | 10 | $309 |
| Otsuka America Pharmaceutical, Inc. | 9 | $199 |
| Alpha Cognition USA, Inc. | 2 | $192 |
| Vanda Pharmaceuticals Inc. | 7 | $187 |
| JAZZ PHARMACEUTICALS INC. | 5 | $155 |
| Axsome Therapeutics, Inc. | 5 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $129 |
| E.R. Squibb & Sons, L.L.C. | 5 | $125 |
| Biogen, Inc. | 4 | $72 |
Products named: SPRAVATO, VRAYLAR, Zunveyl, FANAPT, ABILIFY ASIMTUFII, XYWAV, CAPLYTA, COBENFY.
Industry payments across IL — which companies pay providers there.
